BRO vs CFG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a mixed health profile with a weak Piotroski F-Score of 4/9, indicating borderline financial stability, and no available Altman Z-Score to assess bankruptcy risk. Despite strong revenue growth of 34.20% and solid profitability metrics like a 27.36% operating margin, earnings have declined YoY by -16.10%, creating a divergence between top-line and bottom-line performance. The stock trades above its Graham Number of $52.48 at $79.18, reflecting a premium valuation supported by growth expectations and sector outperformance in revenue. Analysts concur with a 'hold' recommendation, while insider sentiment is neutral and technical indicators suggest bearish momentum.
CFG presents a stark contrast between fundamental value and operational health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is significantly undervalued relative to its Graham Number ($73.23) and Intrinsic Value ($124.49), the low health score and bearish technical trend (10/100) suggest underlying instability. Strong YoY earnings growth of 46.8% and a consistent track record of EPS beats provide a bullish growth narrative, but these are offset by poor deterministic health metrics and bearish insider sentiment.
Compare Another Pair
Related Comparisons
BRO vs CFG: Head-to-Head Comparison
This page compares Brown & Brown, Inc. (BRO) and Citizens Financial Group, Inc. (CFG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.